QQ客服 官方微博 反馈留言

	Secondary prevention of major cerebrovascular events with seven different statins: a multi-treatment meta-analysis
	Zhong Ping[1]; Wu Danhong[2]; Ye Xiaofei[3]; Wu Ying[4]; Li Tuming[5]; Tong Shuwen[6]; Liu Xueyuan[7]
刊名	Drug design, development and therapy
	2017
卷号	11页码:2517-2526
关键词	atherosclerotic cardiovascular disease cerebrovascular event controlled trial primary outcome randomized
ISSN号	1177-8881
URL标识	查看原文
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/2224306
专题	上海大学
作者单位	1.[1]Department of Neurology, Shanghai Tenth People's Hospital, Nanjing Medical University. 2.[2]Department of Neurology, Shanghai Fifth People's Hospital, Fudan University. 3.[3]Department of Statistics, Second Military Medical University. 4.[4]Department of Neurology, Shanghai Traditional Chinese and Western Medicine Hospital, Shanghai University of Traditional Chinese Medicine. 5.[5]Department of Neurology, Shanghai Traditional Chinese and Western Medicine Hospital, Shanghai University of Traditional Chinese Medicine. 6.[6]Department of Neurology, Shanghai Traditional Chinese and Western Medicine Hospital, Shanghai University of Traditional Chinese Medicine. 7.[7]Department of Neurology, Shanghai Tenth People's Hospital, Nanjing Medical University.
推荐引用方式 GB/T 7714	Zhong Ping[1],Wu Danhong[2],Ye Xiaofei[3],et al. Secondary prevention of major cerebrovascular events with seven different statins: a multi-treatment meta-analysis[J]. Drug design, development and therapy,2017,11:2517-2526.
APA	Zhong Ping[1].,Wu Danhong[2].,Ye Xiaofei[3].,Wu Ying[4].,Li Tuming[5].,...&Liu Xueyuan[7].(2017).Secondary prevention of major cerebrovascular events with seven different statins: a multi-treatment meta-analysis.Drug design, development and therapy,11,2517-2526.
MLA	Zhong Ping[1],et al."Secondary prevention of major cerebrovascular events with seven different statins: a multi-treatment meta-analysis".Drug design, development and therapy 11(2017):2517-2526.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。